Jie Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jie Wang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Jian Liu
Department of Rheumatology and Immunology First Affiliated Hospital of Anhui University of Chinese Medicine Hefei Anhui China
2 shared publications Xin Wang
Department of Rheumatology and Immunology, First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei 230031, China
2 shared publicationsJian-Ting Wen
Department of Rheumatology and Immunology, First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei 230031, China
1 shared publication- Jianting Wen
Department of Rheumatology and Immunology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China
1 shared publication - Jin-Chen Guo
School of Traditional Chinese Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, PR China
1 shared publication - Lei Wan
The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China
1 shared publication
Latest Publications
- 1 May 2022
- Vol. 53 (3) , 437-443
类风湿关节炎湿热痹阻证患者外周血单核细胞中circRNA 0003353的变化及其对炎症反应的影响
观察类风湿关节炎(rheumatoid arthritis, RA)湿热痹阻证患者外周血单核细胞(peripheral blood mononuclear cells, PBMCs)中circRNA 0003353的表达,探究其对成纤维样滑膜细胞(fibroblast-like synoviocytes, FLS)炎症反应的影响。 收集本院RA湿热痹阻证患者55例、正常人30例PBMCs及血清,观察circRNA 0003353表达及其与临床指标的相关性。构建circRNA 0003353过表达质粒和小干扰RNA,转染至RA-FLS中;RT-qPCR检测circRNA 0003353表达;酶联免疫吸附法(ELISA)检测白细胞介素(interleukin, IL)-10、IL-17的表达;Western blot检测Janus激酶2(Janus kinase 2, JAK2)、磷酸化(p)-JAK2、信号转导和转录激活因子3(signal transducers and activators of transcription 3, STAT3)、p-STAT3蛋白的表达;CCK-8法检测细胞活力;Transwell实验检测细胞迁移能力。 ①与正常对照组相比,circRNA 0003353在RA湿热痹阻证患者PBMCs中表达升高(PPPPPPPP<0.05)。 circRNA 0003353在RA湿热痹阻证患者中表达上调,通过激活JAK2/STAT3信号通路,促进炎症反应,从而参与RA的发病机制。
- 1 May 2022
- Vol. 53 (3) , 437-443
类风湿关节炎湿热痹阻证患者外周血单核细胞中circRNA 0003353的变化及其对炎症反应的影响
观察类风湿关节炎(rheumatoid arthritis, RA)湿热痹阻证患者外周血单核细胞(peripheral blood mononuclear cells, PBMCs)中circRNA 0003353的表达,探究其对成纤维样滑膜细胞(fibroblast-like synoviocytes, FLS)炎症反应的影响。 收集本院RA湿热痹阻证患者55例、正常人30例PBMCs及血清,观察circRNA 0003353表达及其与临床指标的相关性。构建circRNA 0003353过表达质粒和小干扰RNA,转染至RA-FLS中;RT-qPCR检测circRNA 0003353表达;酶联免疫吸附法(ELISA)检测白细胞介素(interleukin, IL)-10、IL-17的表达;Western blot检测Janus激酶2(Janus kinase 2, JAK2)、磷酸化(p)-JAK2、信号转导和转录激活因子3(signal transducers and activators of transcription 3, STAT3)、p-STAT3蛋白的表达;CCK-8法检测细胞活力;Transwell实验检测细胞迁移能力。 ①与正常对照组相比,circRNA 0003353在RA湿热痹阻证患者PBMCs中表达升高(PPPPPPPP<0.05)。 circRNA 0003353在RA湿热痹阻证患者中表达上调,通过激活JAK2/STAT3信号通路,促进炎症反应,从而参与RA的发病机制。
- 20 March 2022
- Vol. 42 (3) , 367-374
[Triptolide inhibits inflammatory response and migration of fibroblast like synovial cells in rheumatoid arthritis through the circRNA 0003353/JAK2/STAT3 signaling pathway].
To investigate the effect of triptolide (TPL) on inflammatory response and migration of fibroblast like synovial cells (FLS) in rheumatoid arthritis (RA-FLS) and the mechanism of circular noncoding RNA (circRNA) 0003353 for mediating this effect. We collected peripheral blood mononuclear cells (PBMCs) and serum samples from 50 hospitalized RA patients and 30 healthy individuals for detecting the expression of circRNA 0003353, immune and inflammatory indexes (ESR, CRP, RF, anti-CCP, IgA, IgG, IgM, C3, and C4) and DAS28 score. Cultured RA-FLS was treated with 10 ng/mL TPL and transfected with a circRNA 0003353 overexpression plasmid, and cell counting kit-8 (CCK-8) assay and Transwell assay were used to detect the changes in the viability and migration of the cells. Enzyme-linked immunosorbent assay (ELISA) was used to examine the cytokines IL-4, IL-6, and IL-17, and real-time fluorescence quantitative PCR (RT-qPCR) was performed to detect the expression of circRNA 003353; Western blotting was used to detect the expressions of p-JAK2, pSTAT3, JAK2 and STAT3 proteins in the treated cells. The expression of circRNA 0003353 was significantly increased in PBMCs from RA patients and showed a good performance in assisting the diagnosis of RA (AUC=90.5%, P < 0.001, 95% CI: 0.83-0.98). CircRNA 0003353 expression was positively correlated with ESR, RF and DAS28 (P < 0.05). Treatment with TPL significantly decreased the expression of circRNA 0003353, suppressed the viability and migration ability, decreased the expressions of IL-6 and IL-17, and increased the expression IL-4 in cultured RA-FLS in a time-dependent manner (P < 0.01). TNF-α stimulation of RA-FLS significantly increased the ratios of p-JAK2/JAK2 and p-STAT3/STAT3, which were obviously lowered by TPL treatment (P < 0.01). TPL-treated RA-FLS overexpressing circRNA 0003353 showed significantly increased cell viability and migration ability with decreased IL-4 expression and increased IL-6 and IL-17 expressions and ratios of p-JAK2/ JAK2 and p-STAT3/STAT3 (P < 0.01). The expression of circRNA 0003353 is increased in PBMCs in RA patients and in RA-FLS. TPL treatment can regulate JAK2/STAT3 signal pathway and inhibit the inflammatory response and migration of RA-FLS through circRNA 0003353.
- 20 March 2022
- Vol. 42 (3) , 367-374
[Triptolide inhibits inflammatory response and migration of fibroblast like synovial cells in rheumatoid arthritis through the circRNA 0003353/JAK2/STAT3 signaling pathway].
To investigate the effect of triptolide (TPL) on inflammatory response and migration of fibroblast like synovial cells (FLS) in rheumatoid arthritis (RA-FLS) and the mechanism of circular noncoding RNA (circRNA) 0003353 for mediating this effect. We collected peripheral blood mononuclear cells (PBMCs) and serum samples from 50 hospitalized RA patients and 30 healthy individuals for detecting the expression of circRNA 0003353, immune and inflammatory indexes (ESR, CRP, RF, anti-CCP, IgA, IgG, IgM, C3, and C4) and DAS28 score. Cultured RA-FLS was treated with 10 ng/mL TPL and transfected with a circRNA 0003353 overexpression plasmid, and cell counting kit-8 (CCK-8) assay and Transwell assay were used to detect the changes in the viability and migration of the cells. Enzyme-linked immunosorbent assay (ELISA) was used to examine the cytokines IL-4, IL-6, and IL-17, and real-time fluorescence quantitative PCR (RT-qPCR) was performed to detect the expression of circRNA 003353; Western blotting was used to detect the expressions of p-JAK2, pSTAT3, JAK2 and STAT3 proteins in the treated cells. The expression of circRNA 0003353 was significantly increased in PBMCs from RA patients and showed a good performance in assisting the diagnosis of RA (AUC=90.5%, P < 0.001, 95% CI: 0.83-0.98). CircRNA 0003353 expression was positively correlated with ESR, RF and DAS28 (P < 0.05). Treatment with TPL significantly decreased the expression of circRNA 0003353, suppressed the viability and migration ability, decreased the expressions of IL-6 and IL-17, and increased the expression IL-4 in cultured RA-FLS in a time-dependent manner (P < 0.01). TNF-α stimulation of RA-FLS significantly increased the ratios of p-JAK2/JAK2 and p-STAT3/STAT3, which were obviously lowered by TPL treatment (P < 0.01). TPL-treated RA-FLS overexpressing circRNA 0003353 showed significantly increased cell viability and migration ability with decreased IL-4 expression and increased IL-6 and IL-17 expressions and ratios of p-JAK2/ JAK2 and p-STAT3/STAT3 (P < 0.01). The expression of circRNA 0003353 is increased in PBMCs in RA patients and in RA-FLS. TPL treatment can regulate JAK2/STAT3 signal pathway and inhibit the inflammatory response and migration of RA-FLS through circRNA 0003353.